Identification and Management of Pump Thrombus in the HeartWare Left Ventricular Assist Device System: A Novel Approach Using Log File Analysis

JACC: Heart Failure

Volumn 3, Issue 11, 2015, Pages 849-856

  Jorde, Ulrich P ^a   Aaronson, Keith D ^b   Najjar, Samer S ^c   Pagani, Francis D ^b   Hayward, Christopher ^d   Zimpfer, Daniel ^e   Schlöglhofer, Thomas ^e   Pham, Duc T ^f   Goldstein, Daniel J ^a   Leadley, Katrin ^g   Chow, Ming Jay ^g   Brown, Michael C ^g   Uriel, Nir ^h  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d ST VINCENT S HOSPITAL   (Australia)

^e Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

^f TUFTS MEDICAL CENTER   (United States)

^g HEARTWARE INC   (United States)

^h UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

HeartWare ventricular assist device; pump thrombosis; thrombolytics; thrombus; tissue plasminogen activator

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ADVERSE EFFECTS; CLINICAL TRIAL (TOPIC); HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; THROMBOSIS; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84984830208     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2015.06.015     Document Type: Article

References (26)

1. Roger, V.L., Go, A.S., Lloyd-Jones, D.M., et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123 (2011), e18–e209.
2. Rogers, J.G., Aaronson, K.D., Boyle, A.J., et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 55 (2010), 1826–1834.
3. Slaughter, M.S., Pagani, F.D., McGee, E.C., et al. Use of the HeartWare® ventricular assist system for bridge to transplant: combined results of the ADVANCE and CAP Trial. J Heart Lung Transplant 32 (2013), 675–683.
4. Aaronson, K.D., Slaughter, M.S., Miller, L.W., et al. Use of an intrapericardial, continuous flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125 (2012), 3191–3200.
5. Uriel, N., Han, J., Morrison, K.A., et al. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon. J Heart Lung Transplant 33 (2014), 51–59.
6. Starling, R.C., Moazami, N., Silvestry, S.C., et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 370 (2014), 33–40.
7. Najjar, S.S., Slaughter, M.S., Pagani, F.D., et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial. J Heart Lung Transplant 33 (2014), 23–34.
8. Kirklin, J.K., Naftel, D.C., Kormos, R.L., et al. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. J Heart Lung Transplant 33 (2014), 12–22.
9. Capoccia, M., Bowles, C.T., Sabashnikov, A., Simon, A.R., Recurrent early thrombus formation in HeartMate II left ventricular assist device. J Invest Med High Impact Case Rep, 1, 2013, 3.
10. Aissaoui, N., Borgermann, J., Gummert, J., Morshuis, M., HeartWare continuous-flow ventricular assist device thrombosis: the Bad Oeynhausen experience. J Thorac Cardiovasc Surg 143 (2012), e37–e39.
11. Chorpenning, K., Brown, M.C., Voskoboynikov, N., Reyes, C., Dierlam, A.E., Tamez, D., HeartWare controller logs a diagnostic tool and clinical management aid for the HVAD pump. ASAIO J 60 (2014), 115–118.
12. LaRose, J.A., Tamez, D., Ashenuga, M., Reyes, C., Design concepts and principle of operation of the HeartWare ventricular assist system. ASAIO J 56 (2010), 285–289.
13. Kamouh, A., John, R., Eckman, P., Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics. Ann Thorac Surg 94 (2012), 281–283.
14. Santise, G., Sciacca, S., Baglini, R., Clemenza, F., Pilato, M., Can learning to interpret pump messages help lead to an early diagnosis of HeartWare ventricular assist device thrombosis?. ASAIO J 58 (2012), 629–632.
15. Kiernan, M.S., Pham, D.T., DeNofrio, D., Kapur, N.K., Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics. J Thorac Cardiovasc Surg 142 (2011), 712–714.
16. Panteleev, M.A., Balandina, A.N., Lipets, E.N., Ovanesov, M.V., Ataullakhanov Fazoil, I., Task-oriented modular decomposition of biological networks: trigger mechanism in blood coagulation. Biophys J 98 (2010), 1751–1761.
17. Tellor, B.R., Smith, J.R., Prasad, S.M., Joseph, S.M., Silvestry, S.C., The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices. J Heart Lung Transplant 33 (2014), 94–101.
18. Cowger, J.A., Romano, M.A., Shah, P., et al. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant. J Heart Lung Transplant 33 (2014), 35–43.
19. Levin, A., Uriel, N., Takayama, H., et al. Device exchange in HeartMate II recipients: long-term outcomes and risk of thrombosis recurrence. ASAIO J 61 (2015), 144–149.
20. Eckman, P.M., John, R., Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation 125 (2012), 3038–3047.
21. Muthiah, K., Robson, D., Macdonald, P.S., et al. Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device. Artif Organs 37 (2013), 313–318.
22. Goldstein, D.J., John, R., Salerno, C., et al. Algorithm for the diagnosis and management of suspected pump thrombus. J Heart Lung Transplant 32 (2013), 667–670.
23. Salerno, C.T., Sundareswaran, K.S., Schleeter, T.P., Moanie, S.L., Farrar, D.J., Walsh, M.N., Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant 33 (2014), 809–815.
24. Shah, P., Mehta, V.M., Cowger, J.A., et al. Lactate dehyrogenase is superior to serum-free hemoglobin as a marker of pump thombosis in left ventricular assist devices. J Am Coll Cardiol, 61(Suppl), 2013, E665.
25. Uriel, N., Morrison, K.A., Garan, A.R., et al. Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia Ramp Study. J Am Coll Cardiol 60 (2012), 1764–1775.
26. Platts, D., Echocardiographic evaluation of ventricular assist devices. Shuhaiber, J., (eds.) Ventricular Assist Devices, 2011, InTech, Rijeka, Croatia Available at: http://cdn.intechopen.com/pdfs-wm/15746.pdf Accessed December 23, 2014.